New approaches to hematopoietic cell transplantation for hematological diseases in children

Pediatric Clinics of North America

Volumn 49, Issue 5, 2002, Pages 989-1007

  Woodard, Paul ^a   Lubin, Bertram ^b,c   Walters, Mark C ^b,d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE CHEST SYNDROME; ALLOIMMUNIZATION; APLASTIC ANEMIA; BETA THALASSEMIA; BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC GRANULOMATOUS DISEASE; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOSIDEROSIS; HIGH RISK PATIENT; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MORBIDITY; MORTALITY; PANCYTOPENIA; REVIEW; SICKLE CELL ANEMIA; STROKE; THALASSEMIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT;

EID: 0036774454     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(02)00026-3     Document Type: Review

References (88)

1. Anasetti C, Doney KC, Storb R, et al. Marrow transplantation for severe aplastic anemia. Longterm outcome in fifty "untransfused" patients. Ann Intern Med 1986;104:461-6.
2. Boiron J-M, Cotteret S, Cony-Makhoul P, et al. Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia. Bone Marrow Transplant 1998;22:819-21.
3. Bortin MM, Bach FH, van Bekkum DW, et al. 25th anniversary of the first successful allogeneic bone marrow transplants. Bone Marrow Transplant 1994;14:211.
4. De Medeiros CR, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: Reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant 1999;24:849-52.
5. Fischer A, Landais P, Friedrich W, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: A report from the European Group for BMT and the European Group for Immunodeficiency, Blood 1994;83:1149.
6. Horwitz M, Barrett A, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2001;344:881-8.
7. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996;335:369-428.
8. Werner E, Yanovich S, Rubinstein P, Kurtzberg J. Unrelated placental cord blood transplantation in a patient with sickle cell disease and acute non-lymphocytic leukemia. Blood 1997;90 (Suppl 1):399b.
9. Zeidler C, Welte K, Barak Y, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000;95:1195-8.
10. Lucarelli G, Clift RA. Bone marrow transplantation in thalassemia. In: Forman SJ, Blume KG, Thomas ED, editors. Bone Marrow Transplantation, 2nd Edition. Boston: Blackwell Scientific Publications; 1998. p. 1137-1144.
11. Werner EJ, Stout RD, Valdez LP, et al. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia. Pediatrics 1989;83:61.
12. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Farconi anemia. Blood 1995;86:2856-62.
13. Vermylen C, Cornu G, Ferster A, et al. Haematopoietic stem cell transplantation for sickle cell anaemia: The first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998;22: 1-6.
14. Woodard P, Wang W, Pitts N, et al. Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Bone Marrow Transplant 2000;27:589-92.
15. Greinix HT, Storb R, Sanders JE, et al. Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome). Br J Haematol 1993; 84:515.
16. Ghavamzadeh A, Alimoghadam K, Nasseri P, et al. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Bone Marrow Transplant 1999; 23:299-301.
17. Langston A, Sanders J, Deeg J, et al. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol 1996;92:758-65.
18. Ho CML, Vowels MR, Lockwood L, et al. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant 1996;18:213-5.
19. Ozsahin H, von Planta M, Muller I, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes and liposomal amphotericin B. Blood 1998;92:2719-24.
20. Lackner A, Basu O, Bierings M, et al. Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia. Br J Haematol 2000; 109:773-5.
21. MacMillan ML, Davies SM, Wagner JE, et al, Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopenia. Bone Marrow Transplant 1998; 21:735-7.
22. Davies SM, Khan S, Wagner JE, et al: Unrelated donor bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant 1996;17:43-7.
23. Flowers ME, Zanis J, Pasquini R, et al: Marrow transplantation for Fanconi anaemia: Conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol 1996; 92:699-706.
24. Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: Long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998;103:249-55.
25. Buckley R, Schiff S, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508-16.
26. Storb R, Blume K, O'Donnell MR, et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers. Biol Blood Marrow Transplant 2001;7:39-44.
27. Lucarelli G, Clift M, Galimberti M, et al. Bone marrow transplantation in adult thalassemic patients. Blood 1999;93:1164-7.
28. Lucarelli G, Clift RA, Galimberti M, et al. Marrow transplantation for patients with thalassemia: Results in class 3 patients. Blood 1996;87:2082-8.
29. Sykes M, Strober S. Hematopoietic stem cell tranplantation, 2nd edition. In: Thomas ED, Blume KG, Forman SJ, editors. Mechanisms of Tolerance. Malden: Blackwell Science; 1999.
30. Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings. Biol Blood Marrow Transplant 2001;7:473-85.
31. Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant 1996;18:767-76.
32. Socie G, Cayeula JM, Raynal B, et al. Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation. Leukemia 1998;12:1440-6.
33. Andreani M, Manna M, Lucarelli G, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood 1996;87:3494-9.
34. Andreani M, Nesci S, Lucarelli G, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant 2000; 25:401-4.
35. Bader P, Beck J, Frey A, et al. Serial and quantitative analysis or mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998;21:487-95.
36. Childs R, Chernoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343:750-8.
37. Serrano J, Roman J, Herrera C, et al. Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and depletion of CD8+ lymphocytes is associated with a higher incidence of relapse. Bone Marrow Transplant 1999;23:475-82.
38. Van der Straaten HM, Fijnheer R, Dekker AW, et al. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation. Br J Haematol 2001;114:31-5.
39. Lubin BH, Eraklis M, Apicelli G. Umbilical cord blood banking. Adv Pediatr 1999;46:383-408.
40. Amrolia P, Gaspar H, Hassan A, et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiences. Blood 2000;96:1239-46.
41. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998;91: 756-63.
42. McSweeney PA, Storb R. Mixed chimerism: Preclinical studies and clinical applications. Biol Blood Marrow Transplant 1999;5:192-203.
43. Woolfrey A, Pulsipher MA, Storb R. Nonmyeloablative hematapoietic cell transplant for treatment of immune defiency. Current Opinion in Pediatrics 2000;13:539-45.
44. Davies S, Wagner J, Defor T, et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol 1997;96:749-56.
45. Deeg H, Seidel K, Casper J, et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 1999;5:243-52.
46. Wagner JL, Deeg HJ, Seidel K, et al. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. Transplantation 1996;61:54-61.
47. Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: A randomized trial of two irradiation regimens. Blood 1990;76:1867-71.
48. Deeg HJ, Amylon MD, Harris RE, Collins R, Beatty PG, Feig S, et al. Marrow transplants form unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation. Biol Blood Marrow Transplant 2001;7:208-15.
49. Sullivan KM, Anasetti C, Horowitz M, et al. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. Ann N Y Acad Sci 1998;850:312-24.
50. La Nasa G, Giardini C, Locatelli F, et al. Unrelated bone marrow transplantation for thalassemia (preliminary report). Blood 2000;96:414a.
51. Mavroudis D, Read E, Cottler-Fox M, et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996;88:3223-9.
52. Bensinger W, Martin P, Storer B, et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001;344:175-81.
53. Champlin R, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000;95:3702-9.
54. Bonno M, Azuma E, Nakano T, et al. Case report: Successful hematopoietic reconstitution by transplantation of umbilical cord blood cells in a transfusion-dependent child with Diamond-Blackfan anemia. Bone Marrow Transplant 1997;19:83-5.
55. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337:373-81.
56. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
57. Miniero R, Rocha V, Saracco P, et al. Cord blood transplantation (CBT) in hemoglobinopathies. Bone Marrow Transplant 1998;22(suppl 1):S78-9.
58. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
59. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
60. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-9.
61. Wagner JE, Kurtzberg J. Allogeneic umbilical cord blood transplantation. In: Broxmeyer HE, editor. Cellular Characteristics of Cord Blood and Cord Blood Transplantation. Bethesda, Maryland: AABB Press; 1998:113-146.
62. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802.
63. Broxmeyer H, Douglas G, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stemc/progenitor cells. Proc Natl Acad Sci USA 1992;89:3828.
64. Cairo M. Therapeutic implications of dysregulated cytokine colony-stimulating factor expression in neonates. Blood 1993;82:2269.
65. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferative and cytotoxic responses of human cord blood T-lymphocytes following allogeneic stimulation. Cell Immunol 1994;154:14.
66. Laughlin MJ. Umbilical cord blood for allogeneic transplantation in children and adults. Bone Marrow Transplant 2001;27:1-6.
67. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
68. Locatelli F, Rocha V, Reed W, et al. Related cord blood transplant in patients with thalassemia and sickle cell disease. Blood 2001;98:413a.
69. Issaragrisil S, Visuthisakchai S, Suvatte V, et al; Brief Report: Transplantation of cord-blood stem cells into a patient with severe thalassemia. N Eng J of Med 1995;332:367-69.
70. Basara N, Blau WI, Romer E, et al. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients. Bone Marrow Transplant 1998;22: 61-5.
71. Devine SM, Geller RB, Lin LB, et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 1997;3: 25-33.
72. Ratanatharathorn V, Nash RA, Przepiorka D, et al. Phase III study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 1998;92:2303-14.
73. Kahan BD, Julian BA, Pescovitz MD, et al. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial. Rapamune Study Group. Transplantation 1999;68:1526-32.
74. Kahan BD. The potential role of rapamycin in pediatric transplantation as observed from adult studies. Pediatr Transplant 1999;3:175-80.
75. Ciancio G, Carreno M, Mathew J, et al. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. Transplant Proc 1996;28:943-4.
76. Hale G, Zhang MJ, Bunjes D, et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood 1998;92:4581-90.
77. Kernan N, Flomenberg N, DuPont B, et al. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 1987;43:842-7.
78. Mitsuyasu R, Champlin R, Gale RP, et al. Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. Ann Intern Med 1986;105:20-6.
79. Schwinger W, Urban C, Lackner H, et al. Unrelated peripheral blood stem cell transplantation with "megadoses" of purified CD34+ cells in three children with refractory severe aplastic anemia. Bone Marrow Transplant 2000;25:513-7.
80. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Eng J Med 1998; 339:1186-93.
81. Reisner Y, Martelli MF. Tolerance induction by "megadose" transplants of CD34+ stem cells: A new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 2000; 12:536-41.
82. Handgretinger R, Klingebiel T, Lang P, et al. Allografting: Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001;27:777-83.
83. Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood 1999;93:467-80.
84. Vossen JM, Handgretinger R. Immune recovery and immunotherapy after stem cell transplantation in children. Bone Marrow Transplant 2001;28(Suppl 1): 14-5.
85. Green A, Clarke E, Hunt L, et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood 1999;94: 2236-46.
86. Saarinen-Pihkala UM, Gustafsson G, Ringden O, et al. Mellander L for the Nordic Society of Pediatric Hematology and Oncology. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol 2001;19:3406-14.
87. Gustafsson A, Remberger M, Winiarski J, et al. Unrelated bone marrow transplantation in children: Outcome and a comparison with sibling donor grafting, Bone Marrow Transplant 2000;25:1059-65.
88. Margolis D, Camitta B, Pietryga D, et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996;94:65-72.